整合药代动力学与药物代谢组学揭示脉洛舒通丸抗血栓闭塞性脉管炎的多成分协同机制
本研究以月桂酸钠诱导的TAO模型大鼠为对象,整合药代动力学与药物代谢组学方法,评估脉洛舒通丸(MLST)的药效并表征其可入血成分的动态行为。结果显示MLST可显著改善坏疽症状、炎症细胞浸润与血供,10种可入血成分与谷氨酸、组氨酸、花生四烯酸等代谢通路中TAO改变的代谢物存在相关性。
要点
- MLST可改善TAO大鼠坏疽症状、炎症浸润与血供。
- 血浆17种、尿液24种差异代谢物区分TAO与假手术大鼠。
- 10种可入血MLST成分与TAO相关代谢物存在相关性。
核心结论
- MLST通过多成分协同调节谷氨酸、组氨酸、花生四烯酸等代谢通路发挥抗TAO作用。
- 研究首次建立MLST与生物系统之间的动态关联,为阐明其活性成分及协同机制提供依据。
研究设计与样本
- 采用月桂酸钠溶液建立TAO模型大鼠,开展药效评价、药代动力学与药物代谢组学整合研究。
- 药效以坏疽评分、血流速度和H&E染色评价,PK研究针对可入血成分,代谢组学采用非靶向方法分析血浆与尿液。
主要发现
- MLST显著减轻TAO大鼠坏疽症状,改善炎症细胞浸润与血供。
- 假手术与TAO大鼠之间血浆17种、尿液24种差异代谢物存在显著差异。
- 包括绿原酸和芍药苷在内的10种可入血MLST成分与多种TAO改变代谢物呈正相关或负相关。
关键数值与推荐
- 代谢通路分析采用MetaboAnalyst进行,涉及谷氨酸代谢、组氨酸代谢、花生四烯酸代谢等通路。
- 可入血MLST成分与TAO相关内源性代谢物的动态关联通过相关性分析建立。
临床怎么用
- 为MLST抗TAO的活性成分筛选与协同机制研究提供整合PK-PM的研究范式。
- 提示谷氨酸、组氨酸、花生四烯酸代谢通路可作为TAO潜在治疗靶点进一步验证。
局限性
- 研究基于月桂酸钠诱导的TAO模型大鼠,结论外推至临床需进一步验证。
- 原文未报告具体剂量、样本量、P值及置信区间等数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mailuo Shutong Pills (MLST) have displayed pharmacological activity against thromboangiitis obliterans (TAO). However, the active ingredients and therapeutic mechanism of MLST against TAO remained to be further clarified. PURPOSE: The aim of this study was to explore the active components of MLST and their synergistic mechanism against TAO by integrating pharmacokinetics (PK) and pharmacometabolomics (PM). METHODS: TAO model rats were established by sodium laurate solution. Firstly, the efficacy of MLST was evaluated by gangrene score, blood flow velocity, and hematoxylin-eosin (H&E) staining. Secondly, PK research was conducted on bioavailable components to characterize their dynamic behaviors under TAO. Thirdly, multiple plasma and urine metabolic biomarkers for sodium laurate-induced TAO rats were found by untargeted metabolomics, and then variations in TAO-altered metabolites following MLST treatment were analyzed utilizing multivariate and bioinformatic analysis. Additionally, metabolic pathway analysis was performed using MetaboAnalyst. Finally, the dynamic link between absorbed MLST-compounds and TAO-associated endogenous metabolites was established by correlation analysis. RESULTS: MLST significantly alleviated gangrene symptoms by improving the infiltration of inflammatory cells and blood supply in TAO rats. Significant differences in metabolic profiles were found in 17 differential metabolites in plasma and 24 in urine between Sham and TAO rats. The 10 bioavailable MLST-compounds, such as chlorogenic acid and paeoniflorin, showed positive or negative correlations with various TAO-altered metabolites related to glutamate metabolism, histidine metabolism, arachidonic acid metabolism and so on. CONCLUSION: This study originally investigated the dynamic interaction between MLST and the biosystem, providing unique insight for disclosing the active components of MLST and their synergistic mechanisms against TAO, which also shed light on new therapeutic targets for TAO and treatment.
引用
- Wang XB, Wang ML, Chu YJ, et al. Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans. Phytomedicine. 2023. PMID: 36774843. doi:10.1016/j.phymed.2023.154709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。